These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
148 related articles for article (PubMed ID: 27626608)
21. Neuroprotective effects of iron chelator Desferal on dopaminergic neurons in the substantia nigra of rats with iron-overload. Jiang H; Luan Z; Wang J; Xie J Neurochem Int; 2006 Nov; 49(6):605-9. PubMed ID: 16806586 [TBL] [Abstract][Full Text] [Related]
22. Role of flavonoids and iron chelation in antioxidant action. Morel I; Lescoat G; Cillard P; Cillard J Methods Enzymol; 1994; 234():437-43. PubMed ID: 7808316 [No Abstract] [Full Text] [Related]
23. Pharmacokinetics and tissue distribution of deferoxamine-based nanochelator in rats. Jones G; Zeng L; Stiles WR; Park SH; Kang H; Choi HS; Kim J Nanomedicine (Lond); 2022 Sep; 17(22):1649-1662. PubMed ID: 36547231 [TBL] [Abstract][Full Text] [Related]
24. Destructive effect of iron overload in brain tissue of albino rats: Ameliorative role of silver immobilized organo-modified casein nanocomposite as co-treating agent with Deferasirox. Adel RM; Lotfy RA; Darwish AS; Amer AS J Trace Elem Med Biol; 2021 Sep; 67():126794. PubMed ID: 34052583 [TBL] [Abstract][Full Text] [Related]
25. Iron-chelating and free-radical scavenging activities of microwave-processed green tea in iron overload. Srichairatanakool S; Ounjaijean S; Thephinlap C; Khansuwan U; Phisalpong C; Fucharoen S Hemoglobin; 2006; 30(2):311-27. PubMed ID: 16798656 [TBL] [Abstract][Full Text] [Related]
26. Deferoxamine prevents cardiac hypertrophy and failure in the gerbil model of iron-induced cardiomyopathy. Yang T; Brittenham GM; Dong WQ; Levy MN; Obejero-Paz CA; Kuryshev YA; Brown AM J Lab Clin Med; 2003 Nov; 142(5):332-40. PubMed ID: 14647037 [TBL] [Abstract][Full Text] [Related]
27. Effects of kojic acid on oxidative damage and on iron and trace element level in iron-overloaded mice and rats. Kotyzová D; Eybl V; Koutenský J; Brtko J; Glattre E Cent Eur J Public Health; 2004 Mar; 12 Suppl():S41-4. PubMed ID: 15141975 [TBL] [Abstract][Full Text] [Related]
28. A natural antioxidant, tannic acid mitigates iron-overload induced hepatotoxicity in Swiss albino mice through ROS regulation. Basu T; Panja S; Shendge AK; Das A; Mandal N Environ Toxicol; 2018 May; 33(5):603-618. PubMed ID: 29446234 [TBL] [Abstract][Full Text] [Related]
29. The effect of Alnus incana (L.) Moench extracts in ameliorating iron overload-induced hepatotoxicity in male albino rats. Abo-Elghiet F; Mohamed SA; Yasin NAE; Temraz A; El-Tantawy WH; Ahmed SF Sci Rep; 2023 May; 13(1):7635. PubMed ID: 37169909 [TBL] [Abstract][Full Text] [Related]
30. An Indian Desert Shrub 'Hiran Chabba', Farsetia hamiltonii Royle, Exhibits Potent Antioxidant and Hepatoprotective Effect Against Iron- Overload Induced Liver Toxicity in Swiss Albino Mice. Basu T; Kumar B; Shendge AK; Panja S; Chugh H; Gautam HK; Mandal N Curr Drug Discov Technol; 2019; 16(2):210-222. PubMed ID: 29669498 [TBL] [Abstract][Full Text] [Related]
31. Iron Chelators and Antioxidants Regenerate Neuritic Tree and Nigrostriatal Fibers of MPP+/MPTP-Lesioned Dopaminergic Neurons. Aguirre P; Mena NP; Carrasco CM; Muñoz Y; Pérez-Henríquez P; Morales RA; Cassels BK; Méndez-Gálvez C; García-Beltrán O; González-Billault C; Núñez MT PLoS One; 2015; 10(12):e0144848. PubMed ID: 26658949 [TBL] [Abstract][Full Text] [Related]
32. Melatonin: Potential avenue for treating iron overload disorders. Yang J; Tang Q; Zeng Y Ageing Res Rev; 2022 Nov; 81():101717. PubMed ID: 35961513 [TBL] [Abstract][Full Text] [Related]
33. Glycoside rich fraction from Spondias pinnata bark ameliorate iron overload induced oxidative stress and hepatic damage in Swiss albino mice. Chaudhuri D; Ghate NB; Panja S; Basu T; Shendge AK; Mandal N BMC Complement Altern Med; 2016 Jul; 16():262. PubMed ID: 27472924 [TBL] [Abstract][Full Text] [Related]
34. Iron metabolism and oxidative stress during acute and chronic phases of experimental inflammation: effect of iron-dextran and deferoxamine. Muntané J; Puig-Parellada P; Mitjavila MT J Lab Clin Med; 1995 Nov; 126(5):435-43. PubMed ID: 7595028 [TBL] [Abstract][Full Text] [Related]
35. Risk/benefit assessment, advantages over other drugs and targeting methods in the use of deferiprone as a pharmaceutical antioxidant in iron loading and non iron loading conditions. Kontoghiorghes GJ; Efstathiou A; Kleanthous M; Michaelides Y; Kolnagou A Hemoglobin; 2009; 33(5):386-97. PubMed ID: 19814684 [TBL] [Abstract][Full Text] [Related]